• No results found

Adoptive T cell therapy as treatment for Epstein Barr Virus-associated malignancies : strategies to enhance potential and broaden application

N/A
N/A
Protected

Academic year: 2021

Share "Adoptive T cell therapy as treatment for Epstein Barr Virus-associated malignancies : strategies to enhance potential and broaden application"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Adoptive T cell therapy as treatment for Epstein Barr Virus-associated

malignancies : strategies to enhance potential and broaden

application

Straathof, K.C.M.

Citation

Straathof, K. C. M. (2006, September 28). Adoptive T cell therapy as treatment for Epstein

Barr Virus-associated malignancies : strategies to enhance potential and broaden

application. Retrieved from https://hdl.handle.net/1887/4579

Version:

Corrected Publisher’s Version

License:

Licence agreement concerning inclusion of doctoral thesis in the

Institutional Repository of the University of Leiden

Downloaded from:

https://hdl.handle.net/1887/4579

(2)

Referenties

GERELATEERDE DOCUMENTEN

To test this hypothesis CTLs were sorted for low, intermediate and high expression of the linked marker gene GFP and mixed 1:1 with non-transduced CTLs from the same donor to

When melano- ma patients received cyclophosphamide and fludarabine prior to the adoptive transfer of large numbers of highly-activated melanoma-specific tumor infiltrating

This last strategy, commonly referred to as adoptive T-cell therapy has the advantage that the tumor antigen can be presented to the T-cells in an ideal context (on

Dit proefschrift beschrijft onderzoek naar adoptieve T-cel therapie als behandeling voor tumoren die geassocieerd zijn met het Epstein Barr virus (EBV) en strategieën om deze vorm

Adoptive T cell therapy as treatment for Epstein Barr Virus- associated malignancies : strategies to enhance potential and broaden application..

Na het voltooien van haar co-assistentschappen in het LUMC en geaffilieerde ziekenhuizen (1998-2000) en het behalen van het arstexamen (cum laude) was zij van oktober 2000 tot

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in

Blades and blade fragments seem to have been especially used for longitudinal motions, mainly on plant material (7/12). Flake and flake fragments are used in different motions on